What Is a Hemangioma and What Are Its Symptoms?
A hemangioma (often spelled haemangioma) is a benign vascular lesion formed by an abnormal collection of extra blood vessels in or beneath the skin. While they can develop in adults, infantile hemangiomas are the most common benign skin tumours in early childhood. These growths often appear during the first few weeks of life, initialising as a flat red mark before entering a rapid proliferation phase.
Depending on the depth of the blood vessels, hemangiomas present in different ways:
- Superficial hemangiomas: Often termed "strawberry marks", these appear bright red, raised, and firm on the skin's surface.
- Deep hemangiomas: Situated beneath the dermis, these present as soft, bluish or flesh-coloured swellings, sometimes with visible tiny veins nearby.
- Mixed hemangiomas: These feature both superficial red surface components and deeper subcutaneous involvement.
Although most hemangiomas eventually involute (shrink naturally) over several years, active evaluation by a dermatology specialist is essential if the lesion grows rapidly, breaks down to form an open sore (ulceration), bleeds, or compromises vital functions like sight, breathing, or feeding.
How Is a Hemangioma Diagnosed in Turkey?
When seeking specialist care in Turkey, international patients undergo a structured evaluation to assess the lesion's depth, vascular flow, and potential impact on nearby organs. Diagnostic protocols typically involve comprehensive physical examinations alongside targeted imaging techniques available through check-ups & diagnostics departments.
Key diagnostic steps include:
- Clinical Examination: Direct visual inspection and palpation to measure the size, texture, and margin of the lesion.
- Dermatoscopy: High-magnification surface evaluation to inspect microvascular patterns.
- Duplex Ultrasound: A non-invasive scan to evaluate blood flow velocity, vessel density, and the boundary between the lesion and healthy tissue.
- MRI or CT Scans: Utilised primarily for large, deep, or peri-orbital lesions to ensure there is no deeper anatomical involvement or pressure on internal structures. In complex cases, multidisciplinary reviews involving paediatrics or eye surgery teams are arranged.
Patients travelling from abroad should bring existing medical history, previous photographic records showing lesion growth over time, and any prior imaging scans on a USB drive or CD.
Treatment Options for Hemangioma
Management strategies depend entirely on the patient's age, the lesion's phase (proliferative versus involuting), depth, and whether functional impairment or ulceration is present. The treating physician determines the appropriate intervention after thorough clinical evaluation.
| Option |
Typically Used When |
Things to Know |
| Active Monitoring |
Small, non-ulcerated lesions not threatening vital organ function. |
Requires periodic measurement and photographs to track natural regression safely. |
| Topical / Oral Beta-Blockers |
First-line therapy for growing infantile hemangiomas under strict medical supervision. |
Systemic therapies require baseline cardiac checks; helps reduce vascularity and growth rate. |
| Vascular Laser Therapy |
Superficial red marks, residual telangiectasias, or early ulcerated surfaces. |
Targeted light energy closes superficial vessels; may require multiple sessions. |
| Surgical Excision |
Resistant, pedunculated, or heavily scarred residual tissue following natural involution. |
Performed by specialists in plastic & aesthetic surgery or general surgery when non-invasive methods are insufficient. |
Planning Your Medical Travel to Turkey
Organising treatment for a hemangioma in Turkey requires clear coordination before departure. A pre-travel remote record review allows the clinical team to determine whether an in-person consultation is beneficial and if preliminary non-invasive imaging should be booked upon arrival.
For non-surgical interventions or initial diagnostic assessments, an overseas stay of 3 to 5 days is typically sufficient. If laser therapy or surgical excision is planned, a stay of 7 to 10 days allows for safe post-procedure monitoring and wound care checks. Before returning home, your medical team will provide detailed discharge summaries and a clear plan for your local healthcare provider to monitor long-term recovery.
When Travel Is Not Advisable and Urgent Warning Signs
Medical travel should be postponed if an infant or adult patient is medically unstable or has unmanaged systemic health conditions. Specifically, severe systemic beta-blocker contraindications (such as unmonitored cardiac arrhythmias or severe reactive airway disease) must be resolved locally before travelling.
Seek immediate local emergency medical care rather than attempting long-distance travel if any of the following arise:
- Severe, uncontrolled bleeding from an ulcerated hemangioma.
- Sudden rapid swelling near the airway causing stridor, coughing, or difficulty breathing.
- Signs of severe infection, including spreading redness, warmth, pus, or persistent high fever.
- Rapid visual changes or inability to open an eye due to peri-orbital swelling.
